Skip to main content
SpringerLink
Log in

New Guideline Recommendations on Hypertension: Preventing CVD and Renal Disease with Applications to Blacks

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 688 Accesses

Abstract

A number of unique features distinguish hypertension in Blacks from other populations, and attempts to address these features have been incorporated into multiple national and international guidelines. Although there remains a significant lack of data, over the past decade several clinical outcome trials with sufficient sample size of Blacks have been completed. The results of these trials have informed these guideline recommendations and resulted in several common themes. However, differences in the interpretation of the trial results as well as differences in the methodology used to develop the guidelines have led to significant differences in recommendations. The objective of this chapter is to compare both the recommendations and the evidence base and rationale forming the basis for current recommendations for the treatment of hypertension in Black-hypertensive populations. Guidelines selected for review are those that specifically indicate recommendations in Black populations or that reviewed studies conducted in Black-hypertensive patients though not specifically making recommendations by race. In patients requiring the use of BP lowering medications for concomitant disorders (e.g., coronary heart disease, heart failure, proteinuric chronic kidney disease) in addition to treating hypertension, the focus of the chapter will be on recommendations for lowering elevated blood pressure assuming the addition of the agents specifically indicated for the treatment of non-blood pressure-related disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Flack J, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm Jr RH, et al. Management of high blood pressure in African Americans: an update of the ISHIB Consensus Statement. Hypertension. 2010;56:780–800.

    Article  CAS  PubMed  Google Scholar 

  2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.

    Article  PubMed  Google Scholar 

  3. Heffernan KS, Jae SY, Wilund KR, Woods JA, Fernhall B. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295(6):H2380–7.

    Article  PubMed  Google Scholar 

  4. Neaton JD, Grimm Jr RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270(6):713–24.

    Article  CAS  PubMed  Google Scholar 

  5. Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;374(9689):525–33.

    Article  PubMed  Google Scholar 

  6. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685–97.

    Article  CAS  PubMed  Google Scholar 

  7. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417–28.

    Article  CAS  PubMed  Google Scholar 

  8. Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2013;62(15):1396–8.

    Article  PubMed  Google Scholar 

  9. Gibbons GH, Harold JG, Jessup M, Robertson RM, Oetgen WJ. The next steps in developing clinical practice guidelines for prevention. Circulation. 2013;128(15):1716–7.

    Article  PubMed  Google Scholar 

  10. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo Jr JL, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115(21):2761–88.

    Article  PubMed  Google Scholar 

  11. Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino Jr R, Ferdinand K, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20):2049–57.

    Article  CAS  PubMed  Google Scholar 

  12. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57(20):2037–114.

    Article  PubMed  Google Scholar 

  13. Bakris GL, Sarafidis PA, Weir MR, Dahlof B, Pitt B, Jamerson K, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet. 2010;375(9721):1173–81.

    Article  CAS  PubMed  Google Scholar 

  14. Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-DeHoff RM, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123(8):719–26.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Cooper-DeHoff RM, Aranda Jr JM, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, et al. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients—findings from the International Verapamil SR/Trandolapril Study (INVEST). Am Heart J. 2006;151(5):1072–9.

    Article  PubMed  Google Scholar 

  16. Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, et al. Effects of intensive blood pressure control in type 2 diabetes. N Engl J Med. 2010;362:1575–85.

    Article  PubMed  Google Scholar 

  17. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265(24):3255–64.

    Google Scholar 

  18. Go AS, Bauman M, King SM, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63(4):878–85.

    Article  CAS  PubMed  Google Scholar 

  19. Levin A, Stevens PE, Bilous RW, Coresh J, de Francisco ALM, de Jong PE, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;84(3):622–3.

    Google Scholar 

  20. Levin A, Stevens PE. Summary of KDIGO, CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2012;2013.

    Google Scholar 

  21. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367(23):2204–13.

    Article  CAS  PubMed  Google Scholar 

  22. Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547–53.

    Article  CAS  PubMed  Google Scholar 

  23. National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults: clinical guidelines: methods, evidence and recommendations. National Institute for Health and Clinical Excellence. 2011.

    Google Scholar 

  24. National Collaborating Centre for Chronic Conditions. Hypertension: management of hypertension in adults in primary care: partial update. London: Royal College of Physicians; 2006.

    Google Scholar 

  25. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–97.

    Article  Google Scholar 

  26. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.

    Article  CAS  PubMed  Google Scholar 

  27. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical Practice Guidelines for the Management of Hypertension in the Community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26.

    Article  Google Scholar 

  28. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    Article  CAS  PubMed  Google Scholar 

  29. Institute of Medicine. Clinical practice guidelines we can trust. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors. http://www.nap.edu/openbook.php?record_id=13058&page=R1. 2011. Washington, DC, National Academies Press

  30. Hsu CC, Sandford BA. The Delphi technique making sense of consensus. Practical Assess Res Eval. 2007;12(10):1–8.

    Google Scholar 

  31. Nwankwo T, Yoon SS, Burt VL, Gu Q. Hypertension among adults in the United States. National Health and Nutrition Examination Survey 2011–2012, editor. 133, 1–9. 2013. Hyattsville, MD. NCHS Data Brief.

    Google Scholar 

  32. Distribution of the civilian noninstitutionalized U.S. population for use with the NHANES 2011–2012 survey cycle: by gender, age, and race/Hispanic origin. 2013.

    Google Scholar 

  33. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599–606.

    Article  PubMed  Google Scholar 

  34. Wright JD, Hughes JP, Ostchega Y, et.al. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001–2008; 35, 2011, Hyattsville, MD, National Center for Health Statistics. National Health Statistics Reports.

    Google Scholar 

  35. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2013;45(1):315–53.

    Article  PubMed  Google Scholar 

  36. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–64.

    Article  Google Scholar 

  37. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98.

    Article  CAS  PubMed  Google Scholar 

  38. Canadian Hypertension Education Program. 2012 Canadian Hypertension Education Program Recommendations. Canadian Hypertension Education Program; 2012. http://www.hypertension.ca/chep-recommendations

  39. Wright Jr JT, Fine L, Lackland DT, Ogedegbe O, Himmelfarb CD. Evidence supporting a systolic blood pressure goal of <150 mmHg in patients over age 60 years: the minority view. Ann Intern Med. 2014;160(7):499–503.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospitals Case Medical Center, 11100 Euclid Ave., Bolwell Bldg. Suite 2200, Cleveland, OH, 44106, USA

    Gabriel Thornton M.D. & Jackson T. Wright Jr. M.D., Ph.D.

Authors
  1. Gabriel Thornton M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jackson T. Wright Jr. M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jackson T. Wright Jr. M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Thornton, G., Wright, J.T. (2015). New Guideline Recommendations on Hypertension: Preventing CVD and Renal Disease with Applications to Blacks. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_16

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation